A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma. (Record no. 9577314)

MARC details
000 -LEADER
fixed length control field 01559 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513143628.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199806s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nair, R
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19980611
245 00 - TITLE STATEMENT
Title A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Jun 1998
300 ## - PHYSICAL DESCRIPTION
Extent 2282-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epirubicin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Non-Hodgkin
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ramakrishnan, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nair, N N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saikia, T K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parikh, P M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Joshi, S R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Soman, C S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mukhadan, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dinshaw, K T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Advani, S H
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 82
-- no. 11
-- p. 2282-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p">https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p</a>
Public note Available from publisher's website

No items available.